Table 5. Risk factors for post-ESD bleeding by univariate Poisson regression analysis.
| Factors | Relative Risk [95 %CI] | P-value | |
| CKD stage | 3 | 1 | – 0.028 0.021 |
| 4 5 |
12.0 [1.3 – 110.1] 12.7 [1.5 – 109.1] |
||
| Hemodialysis | No | 1 | 0.004 |
| Yes | 6.6 [1.8 – 24.1] | ||
| Diabetes mellitus | No | 1 | 0.161 |
| Yes | 2.6 [0.7 – 9.9] | ||
| Antithrombogenic agents | No | 1 | 0.211 |
| Yes | 2.3 [0.6 – 9.0] | ||
| Heparin replacement therapy | No | 1 | 0.378 |
| Yes | 2.8 [0.4 – 19.7] | ||
Stages from Kidney Disease Improving Global Outcomes Guidelines: stage 3, eGFR: 30 – 59 mL/min; stage 4, eGFR: 15 – 29 mL/min; stage 5, eGFR: < 15 mL/min.